IL32 and thyroid gland carcinoma: The effect of Isoginkgetin on splicing was also evaluated by studying the expression of interleukin 32 (IL-32) alternative isoforms, where IL-32γ isoform is overexpressed upon the treatment (Table 1), correlating with cell death in cell lines derived from thyroid cancer [19].